Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121Revenue (TTM) $M110Net Margin (%)-16.6Altman Z-Score1.6
Enterprise Value $M134EPS (TTM) $-0.5Operating Margin %-0.7Piotroski F-Score6
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-2.1Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %-13.3Quick Ratio1.7Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %-28.0Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-55.8ROA % (ttm)-14.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-21.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.1ROIC % (ttm)5.0Gross Margin Increase y-yY

Gurus Latest Trades with HBIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HBIOArnold Van Den Berg 2015-03-31 Sold Out -0.12%$5.02 - $5.82
($5.37)
$ 3.54-34%Sold Out0
HBIOArnold Van Den Berg 2013-12-31 Add0.04%$3.758 - $5.07
($4.37)
$ 3.54-19%Add 105.68%190,130
HBIOArnold Van Den Berg 2013-09-30 Buy 0.05%$3.6 - $4.28
($3.93)
$ 3.54-10%New holding92,440
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HBIO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


HBIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Duchemin JeffreyCEO 2015-12-10Buy10,000$3.375.04view
UVEGES GEORGEDirector 2015-12-03Buy3,000$3.326.63view
LEWIS EARL RDirector 2015-12-02Buy27,221$3.287.93view
Gagnon Robert E.CFO 2015-11-12Buy1,500$2.9320.82view
Gagnon Robert E.CFO 2015-11-09Buy3,000$3.0814.94view
Duchemin JeffreyCEO 2015-09-02Buy2,000$4.41-19.73view
KENNEDY JOHN FDirector 2015-09-01Buy2,000$4.33-18.24view
GREEN DAVIDDirector 2015-07-17Sell17,103$5.26-32.7view
GREEN DAVIDDirector 2015-07-14Sell51,597$5.28-32.95view
GREEN DAVIDDirector 2015-04-23Sell118,500$6.03-41.29view

Quarterly/Annual Reports about HBIO:

News about HBIO:

Articles On GuruFocus.com
Latest Stock Trades from Century Management: Buys POT, HWCC, PICO, AU, KGC Jan 15 2014 
Harvard Bioscience Inc. Reports Operating Results (10-Q) Nov 05 2010 
Weekly CEO Buys Highlight: Saul Centers Inc, Harvard Bioscience Inc, BGC Partners Inc., Chatham Lodg Sep 25 2010 
Weekly CEO Buys Highlight: Saul Centers Inc, Spartech Corp, Harvard Bioscience Inc, Rural/Metro Corp Sep 18 2010 
Harvard Bioscience Inc. Reports Operating Results (10-Q) May 07 2010 
Harvard Bioscience Inc. Reports Operating Results (10-Q) Nov 09 2009 
Harvard Bioscience Inc. Reports Operating Results (10-Q) Aug 10 2009 
Harvard Bioscience Inc. Reports Operating Results (10-Q) May 07 2009 
Harvard Bioscience Inc. Reports Operating Results (10-Q/A) Feb 19 2009 

More From Other Websites
HARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... May 27 2016
HARVARD BIOSCIENCE INC Financials May 25 2016
HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report May 16 2016
Harvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2016 By the Numbers May 13 2016
Edited Transcript of HBIO earnings conference call or presentation 12-May-16 12:30pm GMT May 12 2016
Q4 2015 and Q1 2016 Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today May 12 2016
Q1 2016 Harvard Bioscience Inc Earnings Release - Before Market Open May 12 2016
Harvard Bioscience Reports First Quarter 2016 Financial Results May 12 2016
HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 12 2016
Harvard Bioscience reports 1Q loss May 12 2016
Harvard Bioscience reports 1Q loss May 12 2016
Harvard Bioscience Reports First Quarter 2016 Financial Results May 12 2016
Harvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements May 04 2016
Harvard Bioscience Regains Compliance with NASDAQ’s Continued Listing Requirements May 04 2016
Harvard Bioscience reports 4Q loss Apr 29 2016
Harvard Bioscience reports 4Q loss Apr 29 2016
HARVARD BIOSCIENCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 29 2016
Harvard Bioscience Reports Fourth Quarter and Year-End 2015 Results, Preliminary First Quarter 2016... Apr 29 2016
Harvard Bioscience, Inc.: Strong price momentum but will it sustain? Mar 30 2016
Harvard Bioscience Delays Filing of Annual Report on Form 10-K and Announces Preliminary Unaudited... Mar 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)